• DOI:10.1016/S1556-0864(15)31579-3
Corpus ID: 30651522

A Review of First-Line Treatment for Small-cell Lung Cancer

@article{Murray2006ARO,
  title={A Review of First-Line Treatment for Small-cell Lung Cancer},
  author={N. Murray and A. Turrisi},
  journal={Journal of Thoracic Oncology},
  year={2006},
  volume={1},
  pages={270-278}
}

N. Murray, A. Turrisi

Published 2006

Medicine

Journal of Thoracic Oncology

Although small-cell lung cancer (SCLC) makes up a smaller proportion of all lung cancers than it did 25 years ago, it remains a common cause of cancer mortality that requires more clinical and basic research than is currently underway. Trials of newer chemotherapy variations have failed to produce a regimen that is clearly superior to the two-drug combination of etoposide and cisplatin, which remains the standard of care for both limited and extensive stage SCLC. Paradoxically, advances in this… CONTINUE READING

View on Wolters Kluwer

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed